dietary fat influences the mammographic response to exogenous hormones and have proposed that these effects may be mediated through dietary-fat-induced enhancement of the phosphoinositide signal transduction mechanism, secondary to altered mammary membrane phosphoinositide fatty acid composition [6] .
The phosphoinositide fatty acid composition of the platelet membrane has been shown to be resistant to alterations in dietary fatty acid intake [ 7, 81. No studies have been undertaken to determine the susceptibility of mammary epithelial membrane phosphoinositide fatty acid composition to altered fatty acid intake. In the present study, tumour incidence and growth rates of carcinogen-treated animals, and the fatty acid compositions of mammary membrane choline (PC), ethanolamine (PE) and inositol (PI) phospholipids, of tissue from control and carcinogen-treated animals, have been studied in corn-oil, olive-oil and MaxEPA (fish-oil)-fed animals.
Twenty-four, 30-day-old female Sprague-Dawley rats weighing approximately 80 g were treated with the carcinogen ENU (ethylnitrosourea; 5 mg of ENU administered by gastric gavage). Treated animals were randomly assigned to corn-oil, olive-oil or MaxEPA dietary groups. Twenty-four control (non-ENU-treated) animals were also randomly assigned to each of the three dietary groups. Food intakes and body weight were measured weekly and food pots changed daily. Animals in the ENU-treated group were killed when palpable mammary tumours could be felt at weekly examinations (between 16 and 20 weeks postcarcinogen). A control animal from the same dietary group was killed at the same time as the tumour-bearing animal. Tumours and normal mammary tissues were excised and weighed, lipids extracted and phospholipid classes separated by two-stage thin-layer chromatography [9] . PI, PC and PE fractions were analysed for their fatty acid compositions after methylation of hydrolysed phospholipids and se aration using packed-column gas-liquid chromatography r10 g of Silar I OC/100 g of Gas chrom. Q ( 100-120 mesh)].
At 20 weeks after carcinogen administration, tumour incidence rates were significantly lower in MaxEPA (43"/0), compared with olive-oil (73%; P < 0.05), and corn-oil (63%; P< 0.05). -fed animals. In normal mammary tissue from control animals, differences in the fatty acid compositions of the PE and PC, but not the PI fractions, were found in animals fed MaxEPA. In PE, arachidonate (C20,4, ,,-,,) content was lower in MaxEPA (7.78 f I. 16, mean f s.E.M.), compared with corn-oil (13.27 f 1.54; I'< 0.01) and olive-oil ( 10.27 f 1.97; P < 0.05) -fed animals. Docosahexaenoic acid (C??:,, ,,-3) was higher in MaxEPA (4.39 k 0.66) than corn-oil (2.19f0.25; P<0.01) and olive-oil (2.63f0.35; 1'<0.05) -fed animals. Similar, but less marked, differences were found in the PC fraction of MaxEPA-fed animals, but no significant differences in phosphoinositide fatty acid composition were found between any of the three dietary groups. In tumour tissue no differences in the fatty acid composition o f any of the phospholipid classes were found in animals fed diets of different fatty acid composition.
This study has confirmed the protective effects of ti -3 fatty acids against mammary tumour development in carcinogen-treated animals. Failure to detect differences in phosphoinositide fatty acid composition of normal mammary tissue obtained from animals fed diets of different fatty acid composition suggests that the composition of this membrane component is resistant to dietary fatty acid modification. The findings do not support the suggestion that dietary fatty acid-induced changes in phosphoinositide fatty acid composition underlie cnhanced mammogenic responses to exogenous hormones and enhanced tumour incidence rates observed in animals fed high fat diets. oils. Mechanisms proposed to explain the lipid lowering effects of 11 -3-fatty acids include reduced rates of hepatic very-low-density lipoprotein (VLDL) output [ 41, and increased rates of endogenous and exogenous triacylglycerol clearance [ 5 1. Hypertriglyceridaemia is commonly seen in patients with NIDDM (non-insulin-dependent diabetes mellitus) and has been attributed to increased hepatic VLDL synthesis secondary to raised circulating concentrations of both insulin and free fatty acids [6] . It might, therefore, be expected that fish-oils would have particularly beneficial effects in this group of patients. Schectman et at. 171 found lower fasting plasma triacylglycerol concentrations in NIDDM patients following a 4 week period of dietary fish-oil supplementation, whereas Kasim et al. 181, in a similar group of patients, found no effect of fish-oil supplementation on fasting serum triacylglycerol levels. Furthermore, both Fasting total and HI)L concenrrations, and fasting and post-prandiiil triaiylglyiwvl i.otii.i,titriitions in normiil iind diabetic subjects befi) studies reported potentially detrimental effects of fish-oil supplements in this group of patients, since fasting lowdensity lipoprotein (LDL) cholesterol, apo-B and glucose concentrations were raised after the period of fish-oil supplementation. Effects of dietary supplementation with fish-oils on postprandial triacylglycerol concentrations have not been extensively studied in normal subjects and there are no reports in the literature of postprandial triacylglycerol eoncentrations in diabetic subjects taking fish-oil supplements.
In the present study, fasting total and high-density lipoprotein (HDL) cholesterol concentrations were determined in normal subjects ( n = 7), and in subjects with NIDDM ( n = 8), before and 6 weeks after supplementation with fishoil capsules (9 capsules/day providing 2.7 g of I I -3 fatty acids). Fasting and postprandial triacylglycerol concentrations were determined after a standard test meal, before and 6 weeks after the period of fish-oil supplementation. Diabetic subjects being treated for their condition by oral hypoglycaemic agents and diet, or by diet alone, were included in the study. None was suffering gross hyperlipidaemia, liver disease or other medical condition and none was taking drugs likely to influence the outcome of the experiment. Normal subjects were recruited from healthy volunteers none of whom were taking medication or were using oral contraceptives during the period of study.
At each visit, subjects attended after an overnight fast and consumed a standard mixed test meal (1000 kcal, 36 g of protein, 53 g of fat and 100 g of carbohydrate). Subjects consumed the meal within 15 min; blood samples were taken at time zero and at 15 minute intervals for the first hour, and half-hourly intervals for the following 2.5 h. Determinations of total and HDL cholesterol and triacylglycerol concentrations were made on serum samples stored at -20"C, and analyses were carried out within 6 weeks of collection.
The results shown in Table 1 demonstrate that fish-oil supplementation significantly lowered fasting and postprandial triacylglycerol concentrations in normal subjects, but not in diabetic subjects, in whom there was a nonsignificant increase in postprandial triacylglycerol concentrations at the second (post fish-oil), test meal. Total cholesterol concentrations were significantly elevated in the diabetic, but not in the normal subjects. Recent kinetic studies of VLDL and LDL metabolism in miniature pigs have shown that I? -3 fatty acid feeding increases the conversion of VLDL to LDL 191, and this may explain higher total cholesterol concentrations in diabetic subjects, in whom other factors regulating LDL cholesterol concentrations may be abnormal. Failure to observe triacylglycerol lowering effects of I I -3 fatty acids in subjects with NIDDM suggests that the mechanism involved in n -3 fatty acid-induced hypotriglyceridaemia may be defective in this condition.
